logo

For the Inventor, By the Inventor

Edison, NJ, United States of America

Robert G L Shorr

USPTO Granted Patents = 16 

Average Co-Inventor Count = 3.0

ph-index = 8

Forward Citations = 137(Granted Patents)


Company Filing History:

goldMedal5 out of 10 
 
Cornerstone Pharmaceuticals, Inc.
 patents
silverMedal5 out of 8 
 
Rafael Pharmaceuticals, Inc.
 patents
bronzeMedal4 out of 100 
 
Enzon, Inc.
 patents
4. 2 out of 2 
 
Lifeblood Medical Inc.
 patents

Years Active: 2004-2023

Loading Chart...
16 patents (USPTO):Explore Patents
1. 11622950 - Therapeutic methods and compositions for treating pancreatic cancer using 6,8-bis-benzylthio-octanoic acid (2023-04-11),
2. 11065335 - Methods of treating leukemia using compositions containing bis(benzylthio)octanoic acid and ion pairs thereof (2021-07-20),
3. 10391177 - Methods for treating cancer using 6,8-bis (benzylthio) octanonic acid (2019-08-27),
4. 10098955 - Pharmaceutical formulations containing lipoic acid derivatives (2018-10-16),
5. 9872845 - Methods of treating myeloma and lymphoma using compositions containing an ion pair of a lipoic acid derivative (2018-01-23),
6. 9839691 - Methods of treating pancreatic and ovarian cancers using compositions containing an ion pair of a lipoic acid derivative (2017-12-12),
7. 9320726 - Methods of treating colon, lung, and liver cancers using compositions containing an ion pair of a lipoic acid derivative (2016-04-26),
8. 8691873 - Pharmaceutical formulations containing lipoic acid derivatives (2014-04-08),
9. 8263653 - Pharmaceutical formulations containing lipoic acid derivatives (2012-09-11),
10. RE43295 - Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells (2012-04-02),
11. 7632504 - Polyalkylene oxide-modified single chain polypeptides (2009-12-15),
12. 7537885 - Composition for maintaining organ and cell viability (2009-05-26),
13. 7220538 - Composition for maintaining organ and cell viability (2007-05-22),
14. 7150872 - Polyalkylene oxide-modified single chain polypeptides (2006-12-19),
15. 6872393 - Polyalkylene oxide-modified single chain polypeptides (2005-03-29),

Title: **Inventor Spotlight: Robert G L Shorr from Edison, NJ**

Introduction

Robert G L Shorr is a prominent inventor based in Edison, New Jersey, known for his significant contributions to medical technology and pharmaceuticals. With an impressive portfolio of 16 patents, Shorr has focused on developing innovative therapeutic methods targeting serious medical conditions, particularly in oncology.

Latest Patents

Among his latest patents, Robert Shorr has made groundbreaking advancements in cancer treatment. One notable invention is a therapeutic method and compositions for treating pancreatic cancer that utilize 6,8-bis(benzylsulfanyl)octanoic acid, combined with gemcitabine and nab-paclitaxel. This method aims to improve the efficacy of existing treatments for pancreatic cancer, a notoriously difficult disease to manage. Additionally, Shorr has developed methods for treating leukemia, employing pharmaceutical formulations containing bis(benzylthio)octanoic acid and its ion pairs. These formulations are designed to address various medical disorders, including various forms of cancer.

Career Highlights

Throughout his career, Robert Shorr has been associated with notable companies in the pharmaceutical sector, including Cornerstone Pharmaceuticals, Inc., and Rafael Pharmaceuticals, Inc. His work has not only resulted in patented inventions but has also contributed to the advancement of drug therapies that have the potential to save lives.

Collaborations

In the course of his innovative journey, Robert Shorr has collaborated with esteemed colleagues such as Robert J Rodriguez and Rajinder Bhasin. Their collective expertise has undoubtedly enhanced the development and successful implementation of groundbreaking treatments in the realm of cancer therapy.

Conclusion

Robert G L Shorr exemplifies the spirit of innovation in the medical field through his dedication to improving therapeutic approaches for life-threatening diseases. With a strong patent portfolio and fruitful collaborations, his contributions continue to shape the future of cancer treatment and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…